+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infection Drug"

Rhinovirus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Rhinovirus Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Rotavirus Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Rotavirus Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Uncomplicated Urinary Tract Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Uncomplicated Urinary Tract Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Herpes Simplex - Pipeline Insight, 2025 - Product Thumbnail Image

Herpes Simplex - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 75 Pages
  • Global
From
Schistosomiasis - Pipeline Insight, 2025 - Product Thumbnail Image

Schistosomiasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
From
Community-acquired Pneumonia (CAP) - Pipeline Insight, 2025 - Product Thumbnail Image

Community-acquired Pneumonia (CAP) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
West Nile - Pipeline Insight, 2025 - Product Thumbnail Image

West Nile - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
HSV-1 Keratitis - Competitive landscape, 2024 - Product Thumbnail Image

HSV-1 Keratitis - Competitive landscape, 2024

  • Clinical Trials
  • November 2024
  • 60 Pages
  • Global
From
From
From
From
From
Surgical Site Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Surgical Site Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bone Marrow Transplant Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Bone Marrow Transplant Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hospital Infection Therapeutics Market 2025-2029 - Product Thumbnail Image

Hospital Infection Therapeutics Market 2025-2029

  • Report
  • May 2025
  • 231 Pages
  • Global
From
Upper Respiratory Tract Infection Treatment Market 2025-2029 - Product Thumbnail Image

Upper Respiratory Tract Infection Treatment Market 2025-2029

  • Report
  • March 2025
  • 222 Pages
  • Global
From
Loading Indicator

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs. Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more